Creative Details

Quality Score: 6/10

The advertisement promotes LEQVIO, a treatment for LDL-C management, highlighting that over 30% of patients discontinue self-administered PCSK9 mAbs within six months, emphasizing the importance of adherence to treatment.

Creative Information

CID:bebf1f5d-6769-4a07-a117-b9cbec5551b3
CRID:25_6kbc3gjz
Domain:novartis.com
Seat:TTD
Size:300x600
Bid:$4.95
Timestamp:11/4/2025, 4:48:37 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/17/2025, 7:27:17 PM7.21s
    adomain_analysissuccess11/17/2025, 8:04:59 PM3.77s
    adomain_capturesuccess11/17/2025, 8:04:55 PM0.19s
    ad_rendersuccess11/17/2025, 7:27:10 PM21.55s
    brand_mappingsuccess11/17/2025, 6:02:30 PM0.10s

    Analysis Results

    Ad Format: banner

    Brands: Novartis

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x600
    Data Transferred:1507.43 KB
    Render Time:8.48 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Business (IAB3)
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1547.67 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js527.94
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N7437.271112BIOPHARMCOMMUNICATIO/B32840373.413432394;dc_ver=106.314;sz=300x600;u_sd=1;gdpr=0;nel=1;dc_adk=2027040030;ord=6yt0ho;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D7543dffa-ee00-4b84-888c-6ebebdd9d63b%26ag%3Ddx5w9no%26sfe%3D1b4ca314%26sig%3DHh1hcDBGuiDrSh2-zi22RjXNFXcsxNcOuyllPzc66LU.%26crid%3D6kbc3gjz%26cf%3D8772550%26fq%3D0%26t%3D1%26td_s%3Dmail.yahoo.com%26rcats%3Doj8%26mste%3D%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D88%26agsa%3D%26wp%3D5.6413484%26rgz%3D94541%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D8727%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D19.850000000000023%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D%26cc%3D2~KLUv_WMdqREMwgPFFwDj44K4XFtUbk1Uji0qx0WqisHL5YaljwYrACDbxNBSoMoVkUtruFmcfCVZkSZX3VuRJmuL1hZZVckfnliJUuZHFzk0lhD42Bm2eE1EQppJ8KGnoAHWAXSuzD-gU_-RNldPDGrznNJ-O6b1XZ09JO7bj0Buz9XkQibDyJJjQjLpjXZGFDMKh1u-TC6STWeZ2zNpO9n_0jIvofamcSOPC23IsyqbXWRa_u7RpD47S0zugrqPSxZe0X4eGpkyG92jZ8tnlUiDZXc49Ozrx9ttHlOO5mdRJhqaksv88lGnNkw04ybN-pqL27UUM_vx9BPm_ThV5-U1hJ1dMRWN-CWUBo_bIU_cdXyPZ2a2w0CcuovqR95WPvlejAd7XmBe9HQZtc2GS94yKTOLR6l_d0GvdHVb1j__M-jQ5_TSb59uuP25rDwY-Pu90ITLOSwMH1PKQGUZkVcPpWRSYPC4VP7M_PgMXptk0BltFt5P_gpbESJk9uUBM2g-MFhyIQ2UX8_1Wpfb_q_D67_WaR-2f7n2Yz0IoTZXG86UyUSJ0pwdmm6A6VKa97Tg4cHBYYuEa6untLzctzVwbDqvW61aaxXOCwS5pvPsVheWzbY9z7P_y7r_l9FnRRqXmZz53ceWNF4MfJT5JIxC82yt7at4IfDsCSMGOuPFS1wBKeraC8TJpu_61822VocKdbKc-PQ5VWYDQfzAxSYHEU-rEIaOWnCfwbLnpP1oJv3MY2cc7Srbl7RUuYLjh0yavAdZMMw-yz0OlnJwz-5qtUAklIoe2m_nqt7W6ynt7m1_rBDO3wtnbaSz4yZJC8n5A7iYxTdbo0wWPqqpCuJ9IXUrkU7oTZTDISLas9UuyH3QSjqAQbdOhxflOZcASXS2DGnIWvRh3BjV6REquRp9squvtm2-jBsbZLEW7ZXRj6M947RQ-1deUnOYaGhRBm6EWr0jgoIUSSOYzlOgESUZI0iBW2S47scsc09adam0b_cslwH4aDcMwyqc4r8Xd2JVUtMy%26dur%3D1~KLUv_WMFoCgkBgHtBABUBkcKB2xtODZkemUiPAjo6IO5LFhZZ1pud2xkS3F0ekZlMFdDOWJieG1YbmRSNGxCKzdRSlF3a1ZFcFNUU2vxTVRURFN1cHBseVZlbmRvcigImP0bdHRkX3N2X2MyOANAAU3KawpAEvxKYnvsYrcLhR79klfBb5NBdZncJodLcCJJKGr6nbP7Qt4hx-nAcIp-8XgzDL2vCv7DVzbm%26durs%3DbB8qnt%26bdc%3D137%26uidd%3Ducm7H3_3nWkuGmN9jfhiNGFpWpI5BKXhF2hV8TT3iH_PfEFK%26idl%3DXi30070BtJfyI-D7aPlDInZfmdXys4unO7epNLj2giBiIY6oiq4PSPCG81Ccmh6cNaoArm%26testid%3Diavc1%2520%26fpa%3D376%26pcm%3D3%26ict%3DWiFi%26said%3D00d14731-edd7-4521-9393-c76f3aecaf62%26auct%3D1%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=I5-4mUAv7l;gcsr=m;stc=1;chaa=1;sttr=29;prcl=s89.20
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://cdn.doubleverify.com/dvbs_src_internal140.js63.65
    https://ep1.adtrafficquality.google/bg/DPVnEqOOr8GEkyz-5oBqyWDy70NS1PVNM5rSU7EcCeQ.js52.04
    https://s0.2mdn.net/sadbundle/6351812892144027431/f4_i1.png51.28
    https://fonts.googleapis.com/css?family=Lato:300,300i,400,400i,700i,900,900i|Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap44.46
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3